Read + Share
Amedeo Smart
Independent Medical Education
Kolind S, Gaetano L, Assemlal HE, Bernasconi C, et al. Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Mult Scler 2023;29:741-747.PMID: 37148240
Email
LinkedIn
Facebook
Twitter
Privacy Policy